ResearchExpert Perspectives on Controversies and Critical Knowledge Gaps in Breast Cancer Management: Proceedings of the First Bridging the Gaps in Breast Cancer Symposium
ResearchPatient-reported outcomes from DESTINY-Breast04: trastuzumab deruxtecan versus physician's choice of chemotherapy in patients with HER2-low mBC
ResearchUtilizing cohort-level and individual networks to predict best response in patients with metastatic triple negative breast cancer
ResearchReal-World Evaluation of Disease Progression After CDK 4/6 Inhibitor Therapy in Patients With Hormone Receptor-Positive Metastatic Breast Cancer
ResearchDose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib
ResearchAn omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer
ResearchPredictors of long-term durable response in de novo HER2-positive metastatic breast cancer and the real-world treatment experience at two institutions
ResearchQuantitative DCE-MRI prediction of breast cancer recurrence following neoadjuvant chemotherapy: a preliminary study
ResearchCDK 4/6 inhibitors are associated with a high incidence of thrombotic events in women with breast cancer in real-world practice
ResearchCharacterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics